Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma

Hepatology

Volumn 26, Issue 5, 1997, Pages 1189-1194

  Schmidt, C Max ^a   Mckillop, Iain H ^a   Cahill, Paul A ^a   Sitzmann, James V ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PERTUSSIS TOXIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CANCER; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030683642     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260516     Document Type: Article

References (52)

1. Sitzmann JV, Abrams R. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg 1993; 217:149-154.
2. Sitzmann JV, Order S. Immunoradiotherapy for primary nonresectable hepatocellular carcinoma. Surg Clin North Am 1989; 69:393-400.
3. Cunningham ML, Matthews HB. Cell proliferation as a determining factor for the carcinogenicity of chemicals: studies with mutagenic carcinogens and mutagenic noncarcinogens. Toxicol Lett 1995; 82-83:9-14.
4. Malkin D. Regulation of cellular proliferation effects on alteration of normal signalling pathways. Med Pediatr Oncol Suppl 1996; 1:20-24.
5. Birnbaumer L. G proteins in signal transduction. Annu Rev Pharmacol Toxicol 1990; 30:675-705.
6. Post GR, Brown JHG. G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J 1996; 10:741-749.
7. S protein mutations and pituitary tumors: functional correlates and possible therapeutic implications. Metabolism 1996; 4(Suppl. 1):117-119.
8. Gicquel C, Dib A, Bertagna X, Amselem S, Le Bouc Y. Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumorigenesis. Eur J Endocrinol 1995; 133:166-172.
9. Piroli G, Pignataro O, De Nicola AF. Increased activity of type I regulatory subunit of cyclic adenosine 3′5′-monophosphate-dependent protein kinase in estrogen-induced pituitary tumors. J Natl Cancer Inst 1992; 84:1565-1571.
10. Siperstein AE, Miller RA, Landis C, Bourne H, Clark OH. Increased stimulatory G-protein in neoplastic human thyroid tissues. Surgery 1991; 110:949-955.
11. Patya M, Stenzel KH, Novogrodsky A. Differential effects of tumor promoters on cAMP: inhibition of receptor mediated and potentiation of cholera toxin-mediated stimulation. Biochem Biophys Res Commun 1985; 133:904-910.
12. Sharif M, Sasakawa N, Hanley MR. Malignant transformation by G-protein coupled hormone receptors. Mol Cell Endocrinol 1994; 100: 115-119.
13. Muca C, Vallar L. Expression of mutationally activated G alpha s stimulates growth and differentiation of thyroid FRTL5 cells. Oncogene 1994; 9:3647-3653.
14. Siperstein AE, Miller RA, Landis C, Bourne H, Clark OH. Increased stimulatory G-protein in neoplastic human thyroid tissues. Surgery 1991; 110:949-955.
15. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha-chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 1989; 340:692-696.
16. Hermouet S, Merendino JJ, Gutkind JS, Spiegel AM. Activating and inactivating mutations of the alpha subunit of Gi2 protein have opposite effects on proliferation of NIH 3T3 cells. Proc Natl Acad Sci U S A 1991; 88:10455-10459.
17. Pace AM, Wong YH, Bourne HA. Mutant alpha subunit of Gi2 induces neoplastic transformation of Rat-1 cells. Proc Natl Acad Sci U S A 1991; 88:7031-7035.
18. Moxham CM, Hod Y, Malbon CC. Induction of Giα2-specific antisense RNA in vivo inhibits neonatal growth. Science 1993; 260:991-995.
19. Roos E, Van De Pavert HV. Inhibition of lymphoma invasion and liver metastasis formation by pertussis toxin. Cancer Res 1987; 47:5439-5445.
20. Gines P, Li X, Brown SE, Nakamura K, Guzellan PS, Haesley LE, Shrier RW, Nemenoff RA. Inhibitory actions of cyclic adenosine monophosphate and pertussis-toxin define two distinct epidermal growth factor-regulated pathways leading to activation of mitogen activated protein kinase in rat hepatocytes. HEPATOLOGY 1996; 23:1167-1173.
21. Adachi T, Nakashima S, Saji S, Nakamura T, Nozawa Y. Mitogen-activated protein kinase activation in hepatocyte growth factor-stimulated rat hepatocytes: involvement of protein tyrosine kinase and protein kinase C. HEPATOLOGY 1996; 23:1244-1253.
22. Allen DO, Munshower J, Morris HP, Weber G. Regulation of adenylyl cyclase in hepatomas of different growth rates. Cancer Res 1971; 31: 557-560.
23. Criss WE, Muganda P, Sahai A, Morris HP. Cyclic nucleotide metabolism in solid tumor tissues. Adv Exp Med Biol 1977; 92:489-516.
24. 1 stimulation of cyclic adenosine 3′5′-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats. Cancer Res 1973; 33:1970-1974.
25. Emmelot P, Bos CJ. Studies on plasma membranes. XIV. Adenyl cyclase in plasma membrane isolated from rat and mouse livers and hepatomas and its hormone sensitivity. Biochim Biophys Acta 1971; 249:285-292.
26. Leichtling BH, Su YF, Wimalasena J, Harden TK, Wolfe BB, Wicks WD. Studies on cAMP metabolism in cultured hepatoma cells: presence of functional adenylate cyclase despite low cAMP content and lack of hormonal responsiveness. J Cell Physiol 1978; 96:215-223.
27. Butcher FR, Scott DF, Potter VR, Morris HP. Endocrine control of cyclic adenosine 3′5′-monophosphate levels in several morris hepatomas. Cancer Res 1972; 32:2135-2140.
28. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye binding. Ann Biochem 1976; 72:248-254.
29. Cahill PA, Wu Y, Sitzmann JV. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits. J Clin Invest 1994; 93:2691-2700.
30. Bevilacqua M, Norbiato G, Chebat E, Baldi G, Bertora P, Regalia E, Colella G, Gennari L, Vago T. Changes in alpha-1 andbeta-2 adrenoceptor density in human hepatocellular carcinoma. Cancer 1991; 67:2543-2551.
31. Bronstad GO, Gladhuag IP, Haffner F, Rugstad HE, Christoffersen T. The regulation of cyclic AMP levels in cultured MH1C1 rat hepatoma cells and in solid tumors derived from MH1C1 cell inoculates. Anticancer Res 1987; 7:155-160.
32. Vintermyr OK, Mellgren G, Boe R, Doskeland SO. Cyclic adenosine monophosphate acts synergistically with dexamethasone to inhibit the entrance of cultured adult rat hepatocyte into S-phase. J Cell Physiol 1989; 141:371-382.
33. Mailer SM, Wilde PA. Desensitization of adenylate cyclase and cAMP flux during the early stages of liver regeneration. J Cell Physiol 1988; 136:88-94.
34. Diehl AM, Yang SQ, Cote P, Wand GS. Chronic ethanol consumption disturbs G-protein expression and inhibits cyclic AMP-dependent signaling in the regenerating rat liver. HEPATOLOGY 1992; 16:1212-1219.
35. Squinto SP, Block AL, Doucet JP. Epidermal growth factor induction of cellular proliferation and protooncogene expression in growth arrested rat H4IIE hepatoma cells: role of cyclic adenosine monophosphate. Mol Endocrinol 1989; 3:433-436.
36. Sevetson BR, Kong X, Lawrence JJ. Increasing cAMP attenuates activation of mitogen-activated protein kinase. Proc Natl Acad Sci U S A 1993; 90:10305-10309.
37. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW. Inhibition of EGF-activated MAP kinase signaling pathway by adenosine 3′5′-monophosphate. Science 1993; 262:1065-1069.
38. Delafontaine P, Anwar A, Lou H, Ku L. G-protein coupled and tyrosine kinase receptors: evidence that activation of insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest 1996; 97:139-145.
39. Zhang Y, Saez R, Leal MA, Chan AM. Synergism between two growth regulatory pathways: cooperative transformation of NIH3T3 cells by G alpha 12 and c-raf-1. Oncogene 1996; 12:2377-2383.
40. Estival A, Robberecht P, Fanjul M, Rouot B, Hollande E, Vaysse N, Clemente F. Cells retrovirally transfected with fibroblast growth factor-2 isoforms exhibit altered adenylate cyclase activity and G-protein functionality. Biochem J 1996; 315:619-624.
41. Hermouet S, Aznavoorian S, Spiegel AM. In vitro and in vivo growth inhibition of murine melanoma K-1735 cell by a dominant negative mutant alpha subunit of Gi2 protein. Cell Signal 1996; 8:159-166.
42. Kinane TB, Finder JD, Kawashima A, Brown D, Abbate M, Shang C, Fredericks WJ, Rauscher FJ, Sukhatme VP, Ercolani L. Growth of LLC-PK1 cells is mediated by EGR-1 upregulation of G protein alpha i-2 protooncogene transcription. J Biol Chem 1994; 269:27503-27509.
43. Liang MN, Garrison JC. The epidermal growth receptor is coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rat hepatocytes. J Biol Chem 1991; 266:13342-13349.
44. Yang L, Camoratto AM, Baffy G, Raj S, Manning DR, Williamson JR. Epidermal growth factor-mediated signaling of Gi-protein to activation of phospholipases in rat cultured hepatocytes. J Biol Chem 1993; 268: 3739-3746.
45. Luttrel LM, Hawes BE, Van Biessen T, Luttrel DK, Lansing TJ, Lefkowitz RJ. Role of c-SRC tyrosine kinase in G-protein coupled receptor and betagamma subunit mediated activation of mitogen activated protein kinases. J Biol Chem 1996; 271:19443-19450.
46. Winitz S, Russell M, Qian N-X, Gardner A, Dwyer L, Johnson GL. Involvement of ras and raf in the Gi-coupled acetylcholine muscarinic m2 receptor activation of mitogen activated protein (MAP) kinase kinase and MAP kinase. J Biol Chem 1993; 268:19196-19199.
47. Alblas J, Van Corven EJ, Hordijk PL, Milligan G, Moolenaar WH. Gi-mediated activation of the p21 ras-mitogen-activated protein kinase pathway by alpha 2-adrenergic receptors expressed in fibroblasts. J Biol Chem 1993; 268:22235-22238.
48. Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. Increased expression of mitogen activated protein kinase pathway in rat and human hepatocellular carcinoma. FASEB J 1996; 10:A2474.
49. McKillop IH, Cahill PA, Sitzmann JV. Activation of Gia proteins stimulates c-myc expression and cellular proliferation in hepatocellular carcinoma. FASEB J 1996; 10:A132.
50. McKillop IH, Cahill PA, Sitzmann JV. Activation of Giα proteins increases the expression of c-fos and c-jun in hepatocellular carcinoma (HCC). Am Assoc Cancer Res 1996; 37:374.
51. Morimitsu Y, Hsia CC, Kojiro M, Tabor E. Nodules of less differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor alpha and its receptor in different areas of tumor. Hum Pathol 1995; 26:1126-1132.
52. Diehl AM, Yang SQ, Wolfgang D, Wand G. Differential expression of guanine nucleotide-binding proteins enhances cAMP synthesis in regenerating liver. J Clin Invest 1992; 89:1706-1712.